AL
Therapeutic Areas
Radionetics Oncology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed GPCR-targeting programs | Broad range of cancers including breast cancer, lung cancer | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed GPCR-targeting programs | Broad range of cancers including breast cancer, lung cancer | Preclinical |